CTC (Chicago Trading Company)
BNTX icon

CTC (Chicago Trading Company)’s BioNTech BNTX Stock Holding History

CTC (Chicago Trading Company)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,019
Closed -$10.8M – 309
2023
Q4 		$10.8M Sell
1,019
-96
-9% -$9.67K 0.01% 231
2023
Q3 		$12.1M Sell
1,115
-273
-20% -$30.2K 0.01% 222
2023
Q2 		$15M Buy
1,388
+605
+77% +$68K 0.01% 231
2023
Q1 		$9.6M Buy
783
+85
+12% +$11.7K 0.01% 249
2022
Q4 		$10.5M Sell
698
-239
-26% -$36.8K 0.01% 229
2022
Q3 		$12.6M Buy
937
+509
+119% +$77.8K 0.01% 226
2022
Q2 		$6.35M Sell
428
-1,798
-81% -$275K ﹤0.01% 246
2022
Q1 		$37.9M Buy
2,226
+660
+42% +$111K 0.02% 168
2021
Q4 		$40.3M Buy
1,566
+986
+170% +$270K 0.02% 117
2021
Q3 		$15.8M Buy
+580
New +$184K 0.01% 125

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

CTC (Chicago Trading Company)'s BNTX Position: Q1 2024 in Review

CTC (Chicago Trading Company) sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 4,124 shares — an estimated $435K sold.

CTC (Chicago Trading Company) first reported a position in BNTX in Q3 2021 and held it in 7 quarters. The position peaked at $10.5M in Q4 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • CTC (Chicago Trading Company) reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 4,124 BioNTech shares in Q1 2024, an estimated $435K.
  • CTC (Chicago Trading Company) first reported a position in BioNTech in Q3 2021 and held it in 7 quarters.
  • CTC (Chicago Trading Company)'s BioNTech position peaked at $10.5M in Q4 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2024, filed 15 May 2024.